Sign In
Buy XTNT
$0.460
-0.0049 (-1.05%)
At Close: Jun 03, 2026
Xtant Medical Holdings, Inc. (XTNT) Q3 2025 Earnings Call Transcript
10:51am, Tuesday, 11'th Nov 2025
Xtant Medical Holdings, Inc. ( XTNT ) Q3 2025 Earnings Call November 11, 2025 8:30 AM EST Company Participants Sean Browne - President, CEO & Director Scott Neils - Chief Financial Officer Conference
Xtant Medical Reports Third Quarter 2025 Financial Results
04:28pm, Monday, 10'th Nov 2025
Total Revenue of $33.3 Million Increased 19% Year-over-Year Delivers Positive Net Income, Adjusted EBITDA and Operating Cash Flow Reiterates FY25 Revenue Guidance of $131-$135 Million, Representing Gr
Xtant Medical Announces Commercial Launch of CollagenX™
08:00am, Wednesday, 05'th Nov 2025
Launch further expands Xtant's biologics product portfolio to include surgical wound closure BELGRADE, Mont. , Nov. 5, 2025 /PRNewswire/ -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global
Xtant Medical to Announce Third Quarter 2025 Financial Results on November 11, 2025
08:00am, Tuesday, 04'th Nov 2025
BELGRADE, Mont. , Nov. 4, 2025 /PRNewswire/ -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal, orthop
Xtant Medical to Participate in the H.C. Wainwright 27th Annual Global Investment Conference
08:57am, Thursday, 04'th Sep 2025
BELGRADE, Mont. , Sept. 4, 2025 /PRNewswire/ -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal, orth
Xtant Medical Holdings, Inc. (XTNT) Q2 2025 Earnings Call Transcript
10:41am, Tuesday, 12'th Aug 2025
Xtant Medical Holdings, Inc. (NYSE:XTNT ) Q2 2025 Earnings Conference Call August 12, 2025 8:30 AM ET Company Participants Scott C. Neils - Chief Financial Officer Sean E.
Xtant Medical Reports Second Quarter 2025 Financial Results
07:00am, Tuesday, 12'th Aug 2025
Total Revenue of $35.4 Million Increased 18% Year-over-Year Delivers Positive Net Income, Adjusted EBITDA and Operating Cash Flow Raises FY25 Revenue Guidance to $131-$135 Million, Representing Growth
Xtant Medical to Attend the CG 45th Annual Growth Conference
04:01pm, Wednesday, 06'th Aug 2025
BELGRADE, Mont. , Aug. 6, 2025 /PRNewswire/ -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal, orth
Xtant Medical to Announce Second Quarter 2025 Financial Results on August 12, 2025
08:00am, Tuesday, 05'th Aug 2025
BELGRADE, Mont., Aug. 5, 2025 /PRNewswire/ -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal, orthop
Transaction expected to facilitate enhanced focus on Xtant's core businesses Total consideration of approximately $19.2 million allows Xtant to reduce outstanding debt and improve liquidity BELGRADE,
Xtant Medical Announces the Launch of OsteoFactor Pro™
08:00am, Wednesday, 28'th May 2025
Allogeneic Growth Factor Solution to Accelerate Bone Repair BELGRADE, Mont. , May 28, 2025 /PRNewswire/ -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focus
Xtant Medical Holdings, Inc. (XTNT) Q1 2025 Earnings Call Transcript
08:32pm, Monday, 12'th May 2025
Xtant Medical Holdings, Inc. (NYSE:XTNT ) Q1 2025 Earnings Conference Call May 12, 2025 4:30 PM ET Company Participants Brett Maas - Hayden IR Sean Browne - President and Chief Executive Officer Scott
Xtant Medical Reports First Quarter 2025 Financial Results
04:05pm, Monday, 12'th May 2025
Revenue Increases 18% Year-over-Year Delivers Positive Net Income and $1.3 Million in Operating Cash Flow Increases 2025 Revenue Guidance to $127 Million to $131 Million BELGRADE, Mont. , May 12, 2025
Xtant Medical to Issue First Quarter 2025 Financial Results on May 12, 2025
08:00am, Tuesday, 06'th May 2025
BELGRADE, Mont. , May 6, 2025 /PRNewswire/ -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal, orthope
Xtant Medical Launches Trivium™ Advanced Bone Graft for Superior Performance
08:00am, Wednesday, 23'rd Apr 2025
BELGRADE, Mont. , April 23, 2025 /PRNewswire/ -- Xtant Medical Holdings, Inc.(NYSE American:XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal, orthop
